Adding radiation therapy to standard drug treatment can cut in half the death rate from advanced prostate cancer and should become the standard of care globally, Swedish researchers reported.
Their study of more than 800 prostate cancer patients showed that nearly 24 percent of men who got only standard drugs had died after 10 years, compared with just under 12 percent of men who also got radiation treatment.
Adding radiation does not add too many side-effects, they wrote in the journal Lancet Oncology.
“The quality of life and adverse effect profile is acceptable. We therefore suggest that endocrine treatment plus radiotherapy should be the new standard of care for these patients,” Anders Widmark of Umea University in Sweden and colleagues wrote.
“The results should change current practice, making long-term hormonal therapy plus radical radiotherapy the standard of care for men with locally advanced prostate cancer,” Dr. Chris Parker and Dr. Alex Tan of Britain’s Institute of Cancer Research in Sutton, Surrey, wrote in a commentary.
Prostate cancer is the second-leading cancer killer of men, killing 221,000 every year globally, with 679,000 new cases diagnosed.
Read more at Reuters